Bristol Myers Profile

Performance

   

 Odds of Distress 

Check how we calculate scores
Equity ratings for Bristol Myers Squibb Company are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting March 22, 2019 and ending today May 21, 2019. Click here to learn more.
850.00
USD 38  4.28%

Bristol Myers Summary

Bristol Myers Squibb Company (BMYMP) is traded on OTC Market in USA and employs 23,700 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 1390B. Bristol Myers Squibb classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 1.64B outstanding shares of which 10 shares are currently shorted by private and institutional investors with about 0.59 days to cover all short positions. BRISTOL MYER SQUI has accumulated about 6.07B in cash with 5.06B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72.
Check Bristol Myers Probability Of Bankruptcy

Bristol Myers Target Price Odds Analysis

Odds Below 850.0HorizonTargetOdds Above 850.0
13.61%30 days 850.00 86.29%
Based on normal probability distribution, the odds of Bristol Myers to move above current price in 30 days from now is about 86.29% (This Bristol Myers Squibb Company probability density function shows the probability of Bristol Myers Stock to fall within a particular range of prices over 30 days) .

Bristol Myers Squibb Risk Profiles

Bristol Myers Key Fundamentals

Bristol Myers Against Markets

Bristol Myers Vital Trading Data

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people. more
NameBristol Myers Squibb Company
CEO, DirectorLamberto AndreottiView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address345 Park Avenue
ExchangeOTC Market
SectorHealthcare
IndustryDrug Manufacturers - Major
BenchmarkDOW
Websitewww.bms.com
Phone212 546 4000
CurrencyUSD - US Dollar

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
All  Next Launch Module

Bristol Myers Distributions to stockholders

Bristol Myers Corporate Directors

Togo West Independent Director
Karen Vousden Director
Alan Lacy Independent Director
Check also Trending Equities. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Search macroaxis.com